GlobeNewswire by notified

Swift Navigation and Telit Cinterion Partner to Enable Precise Positioning in Ultra-Low Power Applications

Share

The integration of Swift’s Skylark® Precise Positioning Service and Telit Cinterion’s GNSS modules will unlock location-based mobile apps that improve tracking efficiency around the world

SAN FRANCISCO, March 21, 2024 (GLOBE NEWSWIRE) -- Swift Navigation, a market leader in precise positioning technologies for automotive, IoT, and mobile applications, and Telit Cinterion, a leading end-to-end IoT solutions enabler, today unveiled their joint solution to empower ultra-low power consumption devices, such as wearables, robotic lawn mowers, and vehicle tracking devices with precise GNSS positioning. The partnership will help to unlock the next generation of location-based apps for navigation, worker safety, fleet management, asset tracking, and more.

By making it possible for devices to determine their location with centimeter accuracy, precise positioning is already enabling autonomous passenger cars and industrial robots to operate safely. But this technology has historically been challenging to integrate into applications that leverage small, battery-powered devices to navigate roads more precisely and track assets more efficiently.

With the introduction of their joint solution, Telit Cinterion and Swift are tackling this challenge head on. Together with Telit Cinterion’s suite of best-in-class GNSS receivers, Swift’s Skylark® Precise Positioning Service offers uniform precision across entire countries while minimizing power consumption, processing loads, and data transmissions, all at an unbeatable price-to-performance ratio. In even the most challenging environments, such as dense urban areas and canyons, the joint solution dramatically improves location accuracy within seconds.

"We are collaborating with Swift to bring forth a solution that addresses the evolving needs of e-mobility and IoT applications,” said Marco Argenton, Vice President Product Management, IoT Modules at Telit Cinterion. “The integration of Skylark with our GNSS receivers, such as the SE868SY-D module, ensures our customers benefit from enhanced precision without compromising on power efficiency."

“We partnered with Telit Cinterion because they share our commitment to providing innovative solutions that unlock entirely new use cases for precise positioning across industries,” said Holger Ippach, Executive Vice President of Product at Swift Navigation. “We are thrilled to offer a new solution that enables IoT and mobile app developers to harness the power of precise positioning as never before.”

Swift’s Skylark is compliant with industry standards and interoperable with an ever-growing list of GNSS chipsets, modules, receivers, and applications, making it easier and more cost effective to deploy than vertically integrated solutions. To learn more about Skylark interoperable devices visit: https://www.swiftnav.com/device-ecosystem

ABOUT SWIFT NAVIGATION
Swift Navigation is changing the way we understand and navigate the planet. Swift’s precise positioning solutions enable centimeter-level mapping, tracking, and navigation to unlock vehicle autonomy, industrial automation, and digital innovation across industries globally. Some of the largest companies in the world are leveraging Swift’s technology to enable safer driving, deliver autonomous vehicles and equipment, optimize logistics, and unleash next-generation mobile applications for navigation, worker safety, and augmented reality, among others. Learn more about how Swift is building a safer and more connected future at www.swiftnav.com

ABOUT TELIT CINTERION
Telit Cinterion is a global end-to-end IoT solutions enabler providing complete solutions that reduce time to market and costs, delivering custom designed, ready for market connected devices in addition to maintaining the industry's broadest portfolio of enterprise-grade wireless communication and positioning modules, cellular MVNO connectivity plans and management services, edge-cloud software and data orchestration, and IoT and Industrial IoT platforms. As the largest western provider pioneering IoT innovation, Telit Cinterion delivers award-winning and highly secure IoT solutions, modules and services for the industry's top brands. Learn more about Telit Cinterion at www.telit.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f49ddff0-2f4c-4f0f-8676-55f71adc4cd8

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors23.4.2024 19:42:34 CEST | Press release

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patients Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that is often unresectable and commonly diagnosed in the late stages of disease Novartis, a leader in radioligand therapy (RLT), is investigating a portfolio of RLTs to treat a broad range of cancers, including GEP-NETs, lung, prostate, breast, colon, brain and pancreatic cancers Basel, April 23, 2024 – Novartis today announced that the U.S. Food and Drug Administration (FDA) approved Lutathera® (USAN: lutetium Lu 177 dotatate / INN: lutetium (177Lu) oxodotreotide) for the treatment of pediatric patients 12 years and older with somatostatin receptor-positive (SSTR+) gastroenteropancreatic neuroendocrine tumors (GEP-NETs), including foregut, midgut, and hindgut NETs. This approval makes Lutathera the first therapy specifically reviewed and appro

Grant of warrants23.4.2024 19:20:21 CEST | Press release

23 April 2024 Announcement no. 9 Grant of Warrants COPENHAGEN, DENMARK and BOSTON, MA, USA, April 23, 2024 (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has resolved, in accordance with the annual general meeting’s resolution on April 27, 2023, to issue a total of 4,000,000 warrants to members of the Executive Management. Each warrant grants the holder the right to subscribe for one share in BioPorto. The exercise price is DKK 1.23 per share, corresponding to the closing price today on Nasdaq Copenhagen. The warrants are issued in accordance with section 18 a of the Articles of Association. Half of the warrants vest over a 2-year period, and the remaining half upon completion of a qualified capital raise in the Company with terms of qualification (including timing and amount of proceeds) to be defined by the Board of Directors. The warrants are otherwise subject to the Company’s incentive warrant program as included in Appendix 1 o

TrueCommerce leverer globale e-fakturerings- og CTC-løsninger til virksomheder, der har udfordringer med overholdelse23.4.2024 19:10:28 CEST | pressemeddelelse

Virksomheden er ene om at tilbyde en global løsning, der omfatter e-fakturering, CTC-løsninger og et omfattende EDI-netværk, alt sammen problemfritintegreret med B2B e-handels- og ERP-systemer KØBENHAVN, Danmark, April 23, 2024 (GLOBE NEWSWIRE) -- TrueCommerce, en global leverandør af forsyningskæde- og handelspartnerforbindelser, integration og løsninger via flere kanaler, har i dag givet meddelelse om sin globale løsning til e-fakturering og Continuous Transaction Controls (CTC), der gør det muligt for organisationer at holde trit med de konstant skiftende juridiske krav overalt i verden og understøtter elektronisk fakturering, som opfylder de gældende krav. TrueCommerce er en global markedsaktør, der understøtter både e-fakturering og CTC og giver adgang til et omfattende globalt EDI-netværk samt B2B e-handel og ERP-integration. På grund af kompleksiteten i at navigere i et landskab af stadigt skiftende landespecifikke e-faktureringskrav og deadlines, står virksomheder over for en s

Festi hf.: Financial results for Q1 202423.4.2024 19:02:17 CEST | Press release

Key findings Sale of goods amounted to ISK 32,223 million, compared to ISK 29,484 million in the previous year, an increase of 9.3% between years.Gross profit from sales of goods and services amounted to ISK 7,033 million, an increase of 806 million or 12.9% between years.Profit Margins from sales of goods and services were 21.8% and increases by 0.7 p.p. from Q1 2023 but decreases by 1.2 p.p. from Q4 2023.Salaries and other personnel expenses increase by 7.5% and full-time equivalents by 2.5%.EBITDA amounted to ISK 1,898 million compared to ISK 1,401 million in Q1 2023, increase of 35.5% between years. Profit for the quarter amounted to ISK 202 million, or 2.9% of margin, a turnaround of ISK 293 million YoY.Net cash from operating activities was ISK 538 million or 7.6% of margin, compared to ISK 1,238 million last year.Equity at the end of Q1 2024 amounted to ISK 35,140 million with an equity ratio of 36.0%. EBITDA forecast for the year 2024 is raised by ISK 300 million and is now ISK

ASM reports first quarter 202423.4.2024 18:00:00 CEST | Press release

Almere, The Netherlands April 23, 2024, 6 p.m. CET Solid start of the year, Q1 orders supported by GAA and HBM ASM International N.V. (Euronext Amsterdam: ASM) today reports its Q1 2024 results (unaudited). Financial highlights € millionQ1 2023Q4 2023Q1 2024 New orders 647.4 677.5 697.9 yoy change % at constant currencies (6%) (14%) 10% Revenue 710.0 632.9 639.0 yoy change % at constant currencies 40% (7%) (8%) Gross profit margin % 49.4 % 47.2 % 52.9 % Adjusted gross profit margin 1 51.1 % 47.9 % 52.9 % Operating result 204.2 131.5 187.1 Operating result margin % 28.8 % 20.8 % 29.3 % Adjusted operating result 1 221.2 141.0 191.8 Adjusted operating result margin 1 31.2 % 22.3 % 30.0 % Net earnings 380.4 90.9 173.1 Adjusted net earnings 1 183.0 100.3 178.9 1 Adjusted figures are non-IFRS performance measures (previously referred to as "normalized"). Refer to Annex 3 for a reconciliation of non-IFRS performance measures. New orders of €698 million in Q1 2024 increased by 10% at constant

HiddenA line styled icon from Orion Icon Library.Eye